MALToma: A Helicobacter pylori-associated malignancy in transplant patients: A report from the Israel Penn International Transplant Tumor Registry with a review of published literature
Lymphoma, B-Cell, Marginal Zone
Treatment of MALToma with immunosuppression minimization and anti-H. pylori therapy results in a majority of patients becoming disease free. Observation of malignant degeneration into an aggressive, high-grade lymphoma in one patient indicates the malignant potential. Diligent follow-up of these patients with endoscopy and biopsy is therefore indicated.